Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.
2.

Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up.

Graversen PH, Nielsen KT, Gasser TC, Corle DK, Madsen PO.

Urology. 1990 Dec;36(6):493-8.

PMID:
2247914
3.
5.

Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.

Malaeb BS, Rashid HH, Lotan Y, Khoddami SM, Shariat SF, Sagalowsky AI, McConnell JD, Roehrborn CG, Koeneman KS.

Urol Oncol. 2007 Jul-Aug;25(4):291-7.

PMID:
17628294
7.

A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T; Japanese Study Group for Locally Advanced Prostate Cancer.

Jpn J Clin Oncol. 2006 Dec;36(12):789-93. Epub 2006 Nov 2.

8.

Familial prostate cancer: a different disease?

Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH.

J Urol. 1997 Dec;158(6):2197-201.

PMID:
9366343
9.

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.

Cross CK, Shultz D, Malkowicz SB, Huang WC, Whittington R, Tomaszewski JE, Renshaw AA, Richie JP, D'Amico AV.

J Clin Oncol. 2002 Jun 15;20(12):2863-8.

PMID:
12065563
10.
11.

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.

Vicini FA, Ziaja EL, Kestin LL, Brabbins DS, Stromberg JS, Gonzalez JA, Martinez AA.

Urology. 1999 Jul;54(1):111-7. Review.

PMID:
10414736
12.
13.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
14.

Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate.

Petrovich Z, Lieskovsky G, Langholz B, Huberman M, Streeter O, Skinner DG.

Am J Clin Oncol. 2001 Dec;24(6):537-46.

PMID:
11801750
15.

Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions.

Nelson CP, Dunn RL, Wei JT, Rubin MA, Montie JE, Sanda MG.

Urol Oncol. 2003 May-Jun;21(3):213-8.

PMID:
12810209
16.

A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution.

Martinez AA, Gonzalez JA, Chung AK, Kestin LL, Balasubramaniam M, Diokno AC, Ziaja EL, Brabbins DS, Vicini FA.

Cancer. 2000 Jan 15;88(2):425-32.

PMID:
10640977
17.

Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.

Khan MA, Han M, Partin AW, Epstein JI, Walsh PC.

Urology. 2003 Jul;62(1):86-91; discussion 91-2.

PMID:
12837428
18.

Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.

Zincke H, Lau W, Bergstralh E, Blute ML.

J Urol. 2001 Dec;166(6):2208-15.

PMID:
11696737
20.

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Adami HO, Johansson JE; Scandinavian Prostate Cancer Group Study Number 4.

J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54. doi: 10.1093/jnci/djn255. Epub 2008 Aug 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk